Ann Neurol
- SABATINO JJ JR, Cree BAC, Hauser SL
New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond.
Ann Neurol. 2025 Jun 6. doi: 10.1002/ana.27270.
BMC Neurol
- YALCIN GY, Tulek Z, Kurtuncu M
Effect of a nurse-led online patient support program on fatigue, sleep and
quality of life in patients with multiple sclerosis: a quasi-experimental study.
BMC Neurol. 2025;25:238.
- AZIMIRAD M, Hamtaeigashti S, Raeisi H, Looha MA, et al
Prevalence of epsilon toxin-producing Clostridium perfringens isolates among
patients with multiple sclerosis and neuromyelitis optica spectrum disorder in
Iran.
BMC Neurol. 2025;25:234.
- KOUCHAKI E, Bayat S, Asgarian FS
Sleep disorders in patients with multiple sclerosis.
BMC Neurol. 2025;25:237.
J Clin Invest
- POLONIO CM, Quintana FJ
Therapeutic B cell depletion identifies immunoregulatory networks.
J Clin Invest. 2025;135:e189442.
J Neurol
- CHEN H
A disproportionality analysis of nervous system adverse events associated with
disease-modifying therapies in multiple sclerosis: insights from the FDA adverse
event reporting system (FAERS).
J Neurol. 2025;272:445.
- MALUCCHI S, Bava CI, Valentino P, Martire S, et al
Correction: In multiple sclerosis patients a single serum neurofilament light
chain (sNFL) dosage is strongly associated with 12 months outcome: data from a
real-life clinical setting.
J Neurol. 2025;272:444.
- NEYAL N, Krey KJ, Morrison HA, Nathoo N, et al
From checkboxes to emojis: a novel approach to patient-reported outcomes in
multiple sclerosis.
J Neurol. 2025;272:434.
J Neurol Neurosurg Psychiatry
- YAMOUT B, Alroughani R, Mohamed SFA, Al-Mahdawi AM, et al
Comparative effectiveness of natalizumab and anti-CD20 monoclonal antibodies in
relapsing-remitting multiple sclerosis: a real-world propensity-score matched
study.
J Neurol Neurosurg Psychiatry. 2025 Jun 1:jnnp-2024-335704.
Magn Reson Med
- BALAJI S, Wiley N, Dvorak A, Padormo F, et al
Magnetization transfer imaging using non-balanced SSFP at ultra-low field.
Magn Reson Med. 2025;94:602-614.
Mult Scler
- MOCCIA M
Clinical commentary to gender-affirming interventions and prognosis in multiple
sclerosis.
Mult Scler. 2025 Jun 3:13524585251341177. doi: 10.1177/13524585251341177.
- NEYAL N, Nathoo N, Cathcart-Rake EJ, Kantarci OH, et al
Gender-affirming interventions and prognosis in multiple sclerosis.
Mult Scler. 2025 Jun 3:13524585251341174. doi: 10.1177/13524585251341174.
- NOVAKOVA L, Rosenstein I, Axelsson M, Schoonheim MM, et al
Plateau of practice effects and noise with repeat SDMT testing and in multiple
sclerosis.
Mult Scler. 2025 May 31:13524585251344794. doi: 10.1177/13524585251344794.
Neurology
- JIA A, Price TR, Rosner J, Broderick C, et al
Journal Club: Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year
Nationwide Retrospective Cohort Study.
Neurology. 2025;105:e213663.
- GOYNE C, Fair AE, Yilmaz D, Race J, et al
Epigenetic Aging in Pediatric-Onset Multiple Sclerosis.
Neurology. 2025;104:e213673.
- YEH EA
Accelerated Aging in Children With Multiple Sclerosis: Can We Stop the Clock?
Neurology. 2025;104:e213840.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016